CD8A and chronic hepatitis B virus infection: These findings underscore mitochondria as therapeutic targets for rejuvenating antiviral CD8+ T cell responses in HIV‐1 infected individuals (Figure 2B).[20] Similarly, exhausted HBV‐specific CD8+ T cells in chronic hepatitis B show profound mitochondrial dysfunction, impairing their antiviral activity.